• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐多药结核病所致的瘰疬

Scrofula Caused by Multidrug-Resistant Tuberculosis.

作者信息

Pedro Bárbara, Alves Liliana, Magano Rita, Nunes Tomás, Marques Nuno

机构信息

Serviço de Medicina II, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal.

Serviço de Infecciologia, Hospital Garcia de Orta, Almada, Portugal.

出版信息

Eur J Case Rep Intern Med. 2020 Jan 2;7(1):001390. doi: 10.12890/2020_001390. eCollection 2020.

DOI:10.12890/2020_001390
PMID:32015974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6993908/
Abstract

UNLABELLED

Tuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug-resistant tuberculosis (MDR-TB) occurs when at the minimum there is resistance to isoniazid and rifampin. Prevention of new infections of and progression to TB disease is critical to reduce the burden and mortality of this disease. We present the case of a 73-year-old human immunodeficiency virus (HIV)-negative female who presented with cervical lymphadenopathy and who was diagnosed with MDR-TB.

LEARNING POINTS

Tuberculosis is one of the most important causes of morbidity and mortality worldwide and approximately a quarter of the world's population is estimated to be latently infected by Multidrug-resistant tuberculosis lymphadenitis is a rare manifestation of the disease in Portugal.With the advent of multidrug-resistant tuberculosis, disease surveillance by the government should be intensified, with the aim of national and global TB control, focusing on prevention.

摘要

未标注

结核病(TB)是全球十大死因之一。当至少对异烟肼和利福平耐药时,就会出现耐多药结核病(MDR-TB)。预防新感染以及预防发展为结核病对于减轻该疾病的负担和死亡率至关重要。我们报告一例73岁的人类免疫缺陷病毒(HIV)阴性女性病例,该患者出现颈部淋巴结病,被诊断为耐多药结核病。

学习要点

结核病是全球发病和死亡的最重要原因之一,据估计全球约四分之一的人口潜伏感染耐多药结核病。淋巴结炎在葡萄牙是该疾病的一种罕见表现。随着耐多药结核病的出现,政府应加强疾病监测,以实现国家和全球结核病控制为目标,重点在于预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/721f32572ecb/1390_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/1fcb91c7cde5/1390_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/f057fdf3e65c/1390_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/721f32572ecb/1390_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/1fcb91c7cde5/1390_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/f057fdf3e65c/1390_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e7/6993908/721f32572ecb/1390_Fig3.jpg

相似文献

1
Scrofula Caused by Multidrug-Resistant Tuberculosis.耐多药结核病所致的瘰疬
Eur J Case Rep Intern Med. 2020 Jan 2;7(1):001390. doi: 10.12890/2020_001390. eCollection 2020.
2
Tuberculosis结核病
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划:联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
5
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.利福平单耐药结核病与耐多药结核病并不相同:来自南非开普敦的一项描述性研究。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0036421. doi: 10.1128/AAC.00364-21. Epub 2021 Aug 30.
6
Genotyping and molecular detection of multidrug-resistant among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴结核性淋巴结炎病例中耐多药的基因分型与分子检测
New Microbes New Infect. 2017 Oct 24;21:36-41. doi: 10.1016/j.nmni.2017.10.009. eCollection 2018 Jan.
7
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
8
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.洛匹那韦利托那韦与一线和二线抗结核药物在治疗耐多药结核病的 HIV 感染儿童中的药代动力学和药物相互作用。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.00420-17. Print 2018 Feb.
9
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.埃塞俄比亚结核性淋巴结炎患者结核分枝杆菌分离株的耐药性
Indian J Med Res. 2014 Jul;140(1):116-22.
10
Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.埃塞俄比亚西北部耐多药结核病的危险因素:一项病例对照研究。
Transbound Emerg Dis. 2019 Jul;66(4):1611-1618. doi: 10.1111/tbed.13188. Epub 2019 Apr 15.

引用本文的文献

1
Would you Rather Treat? A Rare Case of .你更倾向于治疗吗?一个罕见的……病例
Eur J Case Rep Intern Med. 2025 Jan 7;12(2):004963. doi: 10.12890/2025_004963. eCollection 2025.

本文引用的文献

1
Multidrug-resistant Tuberculosis Lymphadenitis as the Initial Presentation of Secondary Multidrug-resistant Tuberculosis: A Case Report.耐多药结核性淋巴结炎作为继发性耐多药结核病的初始表现:一例报告
Cureus. 2018 Mar 26;10(3):e2363. doi: 10.7759/cureus.2363.
2
Current diagnosis and management of peripheral tuberculous lymphadenitis.外周结核性淋巴结炎的当前诊断和治疗。
Clin Infect Dis. 2011 Sep;53(6):555-62. doi: 10.1093/cid/cir454.